04 August 2017
Delaware
Reporter: Barney Dixon

Boehringer infringed 74 patents, says AbbVie


AbbVie has sued Boehringer Ingelheim for infringing 74 patents relating to its Humira arthritis medication.

In its lawsuit, filed in the US District Court for the District of Delaware on 2 August, AbbVie claimed that Boehringer desired to “reap the rewards of AbbVie’s innovation”.

AbbVie has been issued more than 100 patents for Humira.

Boehringer is attempting to secure a biosimilar version of the Humira medication, but AbbVie said “while the Biosimilar Price Competition and Innovation Act (BPCIA) gives Boehringer an abbreviated regulatory pathway for its biosimilar version of Humira, it does not give Boehringer licence to infringe AbbVie’s patents”.

The BPCIA gave Boehringer the ability to limit the amount of patents that AbbVie can bring in the lawsuit down to eight.

AbbVie warned that when Boehringer provides its 180-day Notice of Commercial Marketing, AbbVie will assert the remaining 66 patents in a second wave of litigation.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
USPTO unveils new filing system
15 December 2017 | Washington DC | Reporter: Barney Dixon
The US Patent and Trademark Office (USPTO) has unveiled a new filing system that will launch in 2018 and be fully implemented by 2019
Innovation has thrived under AIA, according to tech association
14 December 2017 | Washington DC | Reporter: Barney Dixon
The High Tech Investors Alliance has responded to contentions that recent legislation and US Supreme Court decisions, including the Alice Corp v CLS Bank case, have weakened the US patent system
Patent perception must shift, says Schecter
13 December 2017 | London | Reporter: Barney Dixon
Public perception must shift if the US is to find feasible solutions to patent abuse, according to chief patent counsel at IBM Manny Schecter
Patent owners winning in IPR
12 December 2017 | New York | Reporter: Barney Dixon
Patent owners are winning more than losing in IPR proceedings, according to a study from law firm Fitzpatrick, Cella, Harper & Scinto
High tech companies weigh in on Allergan deal
11 December 2017 | Washington DC | Reporter: Barney Dixon
Tech companies have argued that Allergan should not be allowed to circumvent the inter partes review process with its controversial patent deal with the Saint Regis Mohawk Tribe
BlackBerry to pay $137 million to Nokia
08 December 2017 | Waterloo | Reporter: Barney Dixon
BlackBerry will pay $137 million to Nokia after the International Chamber of Commerce’s International Court of Arbitration ruled against the company in a patent licensing dispute
ILO ruling “vote of no confidence” for Battistelli, says CSC
07 December 2017 | Munich | Reporter: Barney Dixon
In an open letter to the EPO’s heads of delegations, the CSC said that it interpreted the ILO’s decision as a “massive vote of no confidence in the president of the EPO"